CompoAtlas

DXN MycoVeggie EU Powder

DXN MycoVeggie EU Powder : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
CITRI RETICULATAECITRI RETICULATAE[0.03g;5g]Not identified
Syzygium aromaticumSyzygium aromaticum[0.03g;5g]Not identified
Cinnamomum zeylanicumCinnamomum zeylanicum[0.03g;5g]Not identified
Illicium verumIllicium verum[0.03g;5g]Not identified
SPIRULINA PLATENSISSPIRULINA PLATENSIS[0.17g;5g]Not identified
Citrus sinensisCitrus sinensis[0.17g;5g]Not identified
Citrus aurantiifoliaCitrus aurantiifolia[0.17g;5g]Not identified
Camellia sinensisCamellia sinensis[0.17g;5g]Not identified
Zea maysZea mays[0.17g;5g]Not identified
Lentinus edodesLentinus edodes[0.23g;5g]Not identified
LYOPHYLLUM DECASTESLYOPHYLLUM DECASTES[0.23g;5g]Not identified
Hericium erinaceusHericium erinaceus[0.23g;5g]Not identified
Cymbopogon citratusCymbopogon citratus[0.23g;5g]Not identified
PLEUROTUS PULMONARIUSPLEUROTUS PULMONARIUS[0.23g;5g]Not identified
Zingiber officinaleZingiber officinale[0.23g;5g]Not identified
Calocybe gambosaCalocybe gambosa[0.23g;5g]Not identified
Morus albaMorus alba[0.41g;5g]Not identified
Apium graveolensApium graveolens[0.41g;5g]Not identified
Ginkgo bilobaGinkgo biloba[0.41g;5g]Not identified
Plantago ovataPlantago ovata[1.19g;5g]Not identified

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Product record

Registration number
MAL20172835TE
Type
Natural product
Published status
PRODUCT APPROVED
Licence holder
DXN PHARMACEUTICAL SDN. BHD.
Manufacturer
DXN PHARMACEUTICAL SDN. BHD.
Registration period starting
2022-05-05
Published validity end
2027-05-05

Original register data

View published fields and their variants
Active ingredients
CITRI RETICULATAE[0.03g;5g],Syzygium aromaticum[0.03g;5g],Cinnamomum zeylanicum[0.03g;5g],Illicium verum[0.03g;5g],SPIRULINA PLATENSIS[0.17g;5g],Citrus sinensis[0.17g;5g],Citrus aurantiifolia[0.17g;5g],Camellia sinensis[0.17g;5g],Zea mays[0.17g;5g],Lentinus edodes[0.23g;5g],LYOPHYLLUM DECASTES[0.23g;5g],Hericium erinaceus[0.23g;5g],Cymbopogon citratus[0.23g;5g],PLEUROTUS PULMONARIUS[0.23g;5g],Zingiber officinale[0.23g;5g],Calocybe gambosa[0.23g;5g],Morus alba[0.41g;5g],Apium graveolens[0.41g;5g],Ginkgo biloba[0.41g;5g],Plantago ovata[1.19g;5g]
Valid until
2027-05-05
Registration date
2022-05-05
Published description
NATURAL PRODUCT
Licence holder
DXN PHARMACEUTICAL SDN. BHD.
Producer
DXN PHARMACEUTICAL SDN. BHD.
Published name
DXN MycoVeggie EU Powder
Published reference
20170207378T
Registration number
MAL20172835TE
Published status
PRODUCT APPROVED

Official source

View the official register, number MAL20172835TE

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • SPIRULINA PLATENSIS
    Read the warning, when it applies and the studies cited

    Spirulina

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Condition of application: Allergic rhinitis.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 28 March 2025

  • Zingiber officinale
    Read the warning, when it applies and the studies cited

    GINGER - ZINGIBER OFFICINALE

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 19 December 2025

  • Ginkgo biloba
    Read the warning, when it applies and the studies cited

    GINKGO - GINKGO BILOBA

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Blumenthal et al. 2000; WHO 1999).

    Sources cited by Health Canada (3)
    • Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Newton (MA): Integrative Medicine Communications; 2000.
    • WHO 1999: World Health Organization. WHO monographs on selected medicinal plants, Volume 1. Geneva (CHE): World Health Organization; 1999.
    • OMS 1999 : Organisation mondiale de la santé (OMS). Monographs on selected medicinal plants, Volume 1. Genève (CHE): Organisation mondiale de la santé; 1999.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking diabetes, high blood pressure or seizure medications (Brinker 2010).

    Sources cited by Health Canada (1)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.

    Contraindications

    Do not use if you are having a surgery (Gardner and McGuffin 2013).

    Sources cited by Health Canada (1)
    • Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. Second Edition. Boca Raton (FL): Taylor and Francis Group; 2013.

    Do not use if you are taking blood thinners or other health products that affect blood coagulation (Gardner and McGuffin 2013; Brinker 2010; Bent 2005).

    Sources cited by Health Canada (3)
    • Bent S, Goldberg H, Padula A, Avins AL. Spontaneous bleeding associated with ginkgo biloba: a case report and systematic review of the literature. Journal of General Internal Medicine 2005;20(7):657-661. PubMed Systematic review
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. Second Edition. Boca Raton (FL): Taylor and Francis Group; 2013.

    Health Canada monograph dated 25 July 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “DXN MycoVeggie EU Powder”, https://compoatlas.com/en/supplements/malaysia/MAL20172835TE-dxn-mycoveggie-eu-powder, updated 27 October 2026.

Enter to analyse, Shift+Enter for a new line